Ixazomib Maintenance Study in Patients With AL Amyloidosis
The purpose of this study is to learn if Ixazomib maintenance treatment (chemotherapy) works to control the disease. Through this study, the investigators hope to learn more about ways to prevent or delay relapse of AL Amyloidosis.
AL Amyloidosis
DRUG: Ixazomib|DRUG: Dexamethasone
event free survival (EFS), (EFS includes organ progression, next antiplasma cell directed therapy or death), 2 years
The purpose of this study is to learn if Ixazomib maintenance treatment (chemotherapy) works to control the disease. Through this study, the investigators hope to learn more about ways to prevent or delay relapse of AL Amyloidosis.